Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Shukla

Showing results (191-200 of 223) with videos related to

Pageof 23
Sort By:
Bioconjugate Chemistry|June 18, 2025
Design and Application of Conjugatable Small Molecule Toll-Like Receptor 4 LigandsYutaro Mahara, Issa Fukuda, Ryuho Tanaka, et al.
ACS Combinatorial Science|June 29, 2017
Identification of Biologically Active Pyrimido[5,4-b]indoles That Prolong NF-κB Activation without Intrinsic ActivityMichael Chan, Alast Ahmadi, Shiyin Yao, et al.
Journal of Medicinal Chemistry|March 12, 2016
Identification of a Human Toll-Like Receptor (TLR) 8-Specific Agonist and a Functional Pan-TLR Inhibitor in 2-AminoimidazolesMallesh Beesu, Giuseppe Caruso, Alex C D Salyer, et al.
Plos One|August 15, 2015
The Imidazoquinoline Toll-Like Receptor-7/8 Agonist Hybrid-2 Potently Induces Cytokine Production by Human Newborn and Adult LeukocytesLakshmi Ganapathi, Simon Van Haren, David J Dowling, et al.
American Journal of Otolaryngology|June 25, 2021
A closer look at 30 day hospital readmissions after head and neck cancer surgeryR Puccia, A Ramamurthi, S E Grond, et al.
Journal of Neuroimmunology|August 11, 2024
IT-DEX and B cell depletion in a child with anti-GAD 65 autoimmune encephalitis presenting as NORSE: A case reportJonathan M Yarimi, Alexander J Sandweiss, Karla P Salazar, et al.
Biomed Research International|November 9, 2018
Discovery of a Novel Microtubule Targeting Agent as an Adjuvant for Cancer ImmunotherapyFumi Sato-Kaneko, Xiaodong Wang, Shiyin Yao, et al.
Vaccine|January 9, 2026
A novel calcium influx inducer and a TLR7 agonist are synergistic co-adjuvants that enhance cross-reactive immunity against influenza in young and aged miceYumi Yokoyama, Shiyin Yao, Renna Cozza, et al.
Vaccine|October 9, 2025
Enhancing vaccine immunogenicity through heterologous prime-boost regimen with multiple nasal boosting with liposomal TLR7 ligandTomoko Hayashi, Shiyin Yao, Fumi Sato-Kaneko, et al.
Frontiers in Pharmacology|April 28, 2022
A Triple High Throughput Screening for Extracellular Vesicle Inducing Agents With Immunostimulatory ActivityNikunj M Shukla, Fumi Sato-Kaneko, Shiyin Yao, et al.
Pageof 23

Showing results (191-200 of 223) with videos related to

Sort By:
Pageof 23
Bioconjugate Chemistry|June 18, 2025
Design and Application of Conjugatable Small Molecule Toll-Like Receptor 4 LigandsYutaro Mahara, Issa Fukuda, Ryuho Tanaka, et al.
ACS Combinatorial Science|June 29, 2017
Identification of Biologically Active Pyrimido[5,4-b]indoles That Prolong NF-κB Activation without Intrinsic ActivityMichael Chan, Alast Ahmadi, Shiyin Yao, et al.
Journal of Medicinal Chemistry|March 12, 2016
Identification of a Human Toll-Like Receptor (TLR) 8-Specific Agonist and a Functional Pan-TLR Inhibitor in 2-AminoimidazolesMallesh Beesu, Giuseppe Caruso, Alex C D Salyer, et al.
Plos One|August 15, 2015
The Imidazoquinoline Toll-Like Receptor-7/8 Agonist Hybrid-2 Potently Induces Cytokine Production by Human Newborn and Adult LeukocytesLakshmi Ganapathi, Simon Van Haren, David J Dowling, et al.
American Journal of Otolaryngology|June 25, 2021
A closer look at 30 day hospital readmissions after head and neck cancer surgeryR Puccia, A Ramamurthi, S E Grond, et al.
Journal of Neuroimmunology|August 11, 2024
IT-DEX and B cell depletion in a child with anti-GAD 65 autoimmune encephalitis presenting as NORSE: A case reportJonathan M Yarimi, Alexander J Sandweiss, Karla P Salazar, et al.
Biomed Research International|November 9, 2018
Discovery of a Novel Microtubule Targeting Agent as an Adjuvant for Cancer ImmunotherapyFumi Sato-Kaneko, Xiaodong Wang, Shiyin Yao, et al.
Vaccine|January 9, 2026
A novel calcium influx inducer and a TLR7 agonist are synergistic co-adjuvants that enhance cross-reactive immunity against influenza in young and aged miceYumi Yokoyama, Shiyin Yao, Renna Cozza, et al.
Vaccine|October 9, 2025
Enhancing vaccine immunogenicity through heterologous prime-boost regimen with multiple nasal boosting with liposomal TLR7 ligandTomoko Hayashi, Shiyin Yao, Fumi Sato-Kaneko, et al.
Frontiers in Pharmacology|April 28, 2022
A Triple High Throughput Screening for Extracellular Vesicle Inducing Agents With Immunostimulatory ActivityNikunj M Shukla, Fumi Sato-Kaneko, Shiyin Yao, et al.
Pageof 23